OMX30 1 601 0,3%  OMXH25 3 946 -0,3%  OMXC20 1 025 0,1%  Dow 22 350 0,0%  Nas 5 932 0,0%  EUR 9,5395 0,2%  USD 7,9900 0,1%  Olja 56,9 0,8%  Guld 1 297 0,0% 

Pfizer Aktie

285,00SEK -2,50SEK -0,87%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Pfizer

2016 2017e 2018e 2019e 2020e
Utdelning 1,20 1,28 1,36 1,42 1,50
Direktavkastning (i %) 3,69 3,57 3,78 3,97 4,19
PE-tal 13,54 13,99 13,01 12,61 11,82
Resultat/aktie 2,40 2,56 2,76 2,84 3,03

Nyheter om Pfizer Inc.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Pfizer Inc.

Sep, 19 2017 Pfizer Outperform Bernstein Research
Sep, 18 2017 Pfizer Hold Jefferies & Company Inc.
Aug, 24 2017 Pfizer Hold Jefferies & Company Inc.
Aug, 15 2017 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Aug, 02 2017 Pfizer Hold Jefferies & Company Inc.
ytterligare analyser

Pfizer Peer Group

Abbott Laboratories 52,50
2,1%
Alexion Pharmaceuticals 142,89
0,0%
Allergan 0,00
0,0%
AstraZeneca 534,00
2,2%
Bayer 110,10
-0,3%
Celgene 143,89
0,1%
EVOTEC 18,70
-0,5%
Gilead Sciences 83,23
0,7%
GlaxoSmithKline 14,74
0,4%
Johnson & Johnson 131,33
-0,3%
Merck 65,13
-0,7%
Merck 96,50
0,1%
MorphoSys 71,00
2,0%
Mylan 31,29
0,1%
Novartis 83,45
0,6%
Perrigo Company 0,00
0,0%
Pfizer 35,94
-0,1%
Roche 248,00
-0,4%
STADA 81,15
0,7%
Sanofi 84,12
0,3%
Teva Pharmaceutical Industries 17,19
0,2%
Vertex Pharmaceuticals 151,29
-0,5%
Warner Chilcott 0,00
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Pfizer Inc.till bolagsprofilen

Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Realtidskurs Pfizer Inc.

Bid 35,89 USD Ask 36,04 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Pfizer Inc. i SEKPUSH CHART

Kurs 285,00 SEK -2,50 -0,87 %
Kurstid 17:29:34
Datum 22.09.2017
Öppning 286,00
Gårdagen 287,50
Dagshögsta 288,50
Dagslägsta 283,00
52 v. högsta 316,00
52 v. lägsta 261,50
52 v. perf.
Volym (Antal) 1 672
Börsvärde (SEK) 1 701,70 Mrd
Börsen

Till aktien Pfizer

Ticker PFE
ISIN US7170811035
Index S&P 100, NYSE US 100, Dow Jones, BX Swiss - USA, S&P 500

Struktuerarde produkter på Pfizer

Produkttyp Antal
Mini Futures 3
Bull-Bear 2

Pfizer Nyckeltal

Börsvärde i SEK 1 701,70 Mrd
Free float % 99,95
Antal aktier mio. 5 947,35
Cashflow/aktie i lokal valuta 2,13
Bokvärde/aktie i lokal valuta 9,67
60 dagar vola 16,05
PBV 3,36

Pfizer Historiska kurser

2017-09-22 285,00 1 672
2017-09-21 287,50 1 696
2017-09-20 284,00 2 460
2017-09-19 282,00 790
2017-09-18 281,00 2 574

Aktier i samma industri med bättre 1 års perf.

Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
Immunomedics Inc. 227,8 %
Array BioPharma Inc. 198,4 %
Pharmacyclics Inc 198,2 %